The level of LRG1 in the cerebrospinal fluid of patients with Parkinson's disease combined with dementia (PDD) and progressive supranuclear palsy (PSP) is significantly increased, while the deposition of LRG1 in the cerebral cortex increases with age. The gene discussed is LRG1; the disease is Parkinson disease.